Anaplastic large cell lymphoma diagnostic criteria

Revision as of 17:18, 14 August 2015 by Jyostna Chouturi (talk | contribs)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to navigation Jump to search

Anaplastic large cell lymphoma Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Anaplastic large cell lymphoma from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Chest X Ray

CT

MRI

Echocardiography or Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Anaplastic large cell lymphoma diagnostic criteria On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Anaplastic large cell lymphoma diagnostic criteria

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Anaplastic large cell lymphoma diagnostic criteria

CDC on Anaplastic large cell lymphoma diagnostic criteria

Anaplastic large cell lymphoma diagnostic criteria in the news

Blogs on Anaplastic large cell lymphoma diagnostic criteria

Directions to Hospitals Treating Anaplastic large cell lymphoma

Risk calculators and risk factors for Anaplastic large cell lymphoma diagnostic criteria

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Diagnostic Criteria

To make this diagnosis under its present system of classification, the WHO:

Requires

  • The presence of "hallmark" cells
  • Immunopositivity for CD30

Acknowledges as typical, but does not require

  • Immunopositivity for ALK (anaplastic lymphoma kinase) protein

Specifically excludes

  • Primary cutaneous T-cell lymphomas
  • Other specific types of anaplastic lymphoma (particularly those of B-cell lineage) with CD30 positivity

References

Template:WH Template:WS